Previous Article | Next Article 
Journal of Virology, February 2000, p. 1994-2004, Vol. 74, No. 4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mutation of Predicted Virion Pit Residues Alters
Binding of Theiler's Murine Encephalomyelitis Virus to BHK-21
Cells
Shannon
Hertzler,1
Ming
Luo,2 and
Howard L.
Lipton3,4,*
Integrated Graduate Program, Northwestern
University Medical School,1 and
Departments of Neurology, Microbiology-Immunology, and
Biochemistry, Molecular Biology, and Cell Biology, Northwestern
University,3 Chicago, and Division
of Neurology, Evanston Hospital, Evanston,4
Illinois, and Center for Macromolecular Crystallography,
University of Alabama, Birmingham, Alabama2
Received 4 August 1999/Accepted 22 November 1999
 |
ABSTRACT |
Theiler's murine encephalomyelitis virus (TMEV), a
natural pathogen of mice, is a member of the genus
Cardiovirus in the family Picornaviridae.
Structural studies indicate that the cardiovirus pit, a deep depression
on the surface of the virion, is involved in receptor attachment;
however, this notion has never been systematically tested. Therefore,
we used BeAn virus, a less virulent TMEV, to study the effect of
site-specific mutation of selected pit amino acids on viral binding as
well as other replicative functions of the virus. Four amino acids
within the pit, V1091, P1153, A1225 and P3179, were selected for
mutagenesis to evaluate their role in receptor attachment. Three amino
acid replacements were made at each site, the first a conservative
replacement, followed by progressively more radical amino acid changes
in order to detect variable effects at each site. A total of seven
viable mutant viruses were recovered and characterized for their
binding properties to BHK-21 cells, capsid stability at 40°C, viral
RNA replication, single- and multistep growth kinetics, and virus
translation. Our data implicate three of these residues in TMEV-cell
receptor attachment.
 |
INTRODUCTION |
Theiler's murine
encephalomyelitis virus (TMEV), a natural pathogen of mice, is a
member of the genus Cardiovirus in the family Picornaviridae, which includes another serogroup, consisting
of a number of isolates, including Mengovirus and
Encephalomyocarditis virus (EMCV). TMEVs can be divided into
two groups based on neurovirulence following intracerebral inoculation
of mice. Highly virulent strains of TMEV, such as GDVII and FA, cause a
rapidly fatal encephalitis, while less virulent strains, such as BeAn
and DA, are characterized by at least a 105-fold increase
in the mean 50% lethal dose. The less virulent TMEVs cause a
persistent infection in the central nervous system of susceptible
strains of mice, resulting in immune-mediated demyelination. This
animal model has been used as an experimental analogue of multiple sclerosis.
The three-dimensional structures of viruses of all picornavirus genera,
except the hepatoviruses, have been solved to an atomic level. TMEVs
are not an exception (12, 21, 22). The Theiler's virion is
composed of a single-strand, positive-sense RNA molecule, 8.1 kb in
size, surrounded by an icosahedral capsid containing 60 copies each of
the four capsid proteins, VP1 (1D), VP2 (1B), VP3 (1C), and VP4 (1D).
VP1, VP2, and VP3, the larger capsid proteins, form the outer capsid
surface, while their amino termini are intertwined on the inside of the
protein shell. VP4 is found exclusively lining the interior surface of
the capsid. VP1, VP2, and VP3 have a common picornavirus folding motif
consisting of an eight-stranded, anti-parallel
-barrel with the
sequences connecting the
-strands forming loops found on the
exterior of the virion. These surface loops contain the major antibody
neutralization sites for picornaviruses, including the cardioviruses
(4, 9, 19).
A deep depression has been observed on the surfaces of human
rhinoviruses (HRV) (13, 18, 29), the polioviruses (PV) (16), coxsackievirus B3 (25), and the
cardioviruses mengovirus and TMEV (12, 21, 23), but not
foot-and-mouth disease virus (FMDV) (1). This surface
depression forms a canyon around the icosahedral fivefold axes on the
surfaces of HRV, PV, and coxsackievirus B3, but is a focal depression
or pit on the cardioviruses, where the prominent VP1 loops I and II,
which have no homology in the other picornaviruses, block the lateral
extension of the pit (12, 21). Diverse experimental
approaches have demonstrated that the canyons of HRV-14 (6),
HRV-16 (26), HRV-2 (10), and PV1 (7, 8,
14) are involved in virion attachment to the host cell receptor.
On the other hand, a conformational change in the pit was found when
mengovirus crystals were grown in the presence of 100 mM phosphate
buffer (pH 7.4) or in
10 mM phosphate in physiological saline (pH
4.6) (17). This conformational change, which involved
movement of the FMDV or GH loop in VP1 and the carboxy terminus of VP2,
and rearrangement of the GH loop in VP3, was associated with loss of
mengovirus binding to host cells (17). These observations
indicate that the cardiovirus pit is involved in receptor attachment;
however, this notion has never been systematically tested by
pinpointing amino acids involved in receptor binding.
The pathogenesis of the less virulent BeAn strain has been intensively
investigated, including the mapping of viral determinants responsible
for persistent infection of mice. We therefore used BeAn virus to study
the effect of site-specific mutation of selected pit amino acids on
viral binding as well as other replicative functions. The TMEV pit,
located in the center of the protomer, is composed of VP1 and VP3
residues and extends toward a large depression at the twofold axis
(12). Four amino acids within the pit, 1091, 1153, 1225, and
3179, were selected for mutagenesis to evaluate their role in receptor attachment.
Radiolabeled-virus binding assays revealed that two of the mutant
viruses, V1091I and P1153A, had dramatic binding differences, while all
of the other characteristics evaluated for these two viruses were
similar to the parental BeAn virus, indicating that these residue
replacements primarily altered the binding phenotype. While R1125A also
showed binding differences, its capsid stability and single-step growth
kinetics were also changed, suggesting that this replacement had also
affected viral processes distinct from receptor attachment.
Substitutions in the VP3 GH loop did not alter the binding phenotype,
suggesting that this surface loop is not directly involved in
TMEV-receptor interaction.
 |
MATERIALS AND METHODS |
Cells and virus infections.
BHK-21 cells were maintained in
Dulbecco's modified Eagle medium (DMEM) supplemented with 2 mM
L-glutamine, 100 mg of streptomycin per ml, 100 U of
penicillin per ml, 7.5% fetal bovine serum (FBS), and 6.5 mg of
tryptose phosphate broth (Gibco/BRL) per ml (hereafter DMEM medium) at
37°C in a 5% CO2 atmosphere. Receptor-negative BHK-21
cells, designated R26, were selected by resistance to BeAn virus
infection and were maintained as the parental BHK-21 cells (S. Hertzler
and H. L. Lipton, unpublished data). Virus infections and plaque
assays were carried out on monolayers that were 90% confluent and in
DMEM medium containing 1% FBS. Viral plaques were assayed on BHK-21
monolayers in 35-mm multiwell plates, by staining with crystal violet
after incubation for 4 days at 33°C in a 5% CO2
atmosphere as previously described (30).
Strategy of site-specific amino acid mutation.
Mutant BeAn
viruses were derived from a plasmid containing the full-length
wild-type BeAn cDNA in pGEM4 (Promega), immediately downstream from the
T7 RNA polymerase promoter (5) (Fig.
1). The plasmid had been modified so that
only two nucleotides separated the T7 RNA polymerase promoter and the
5' end of the virus, and an XbaI site was engineered
immediately downstream of the poly(A) tract at the 3' end. A 2.3-kb
HindIII-KpnI (nucleotides 1729 to 4088)
restriction fragment, spanning the VP1 (1D) and VP3 (1C) sequences and
including all of the potential receptor binding or pit residues, was
cloned into the HindIII-KpnI site of
pGEM7zf(
). This subgenomic construct was used to assemble the
full-length BeAn cDNA following site-directed mutagenesis, since it
contains two unique restriction endonuclease sites, AgeI
(nucleotide 2214) and XhoI (nucleotide 3825), flanking the
VP1 and VP3 sequences. From this 2.3-kb subgenomic clone, two smaller
restriction fragments, 0.7-kb SpeI-NdeI
(nucleotides 2826 to 3523) and 0.3-kb NdeI-AatII (nucleotides 3523 to 3914), were cloned into pGEM5zf(+) to facilitate nucleotide sequencing after site-directed mutagenesis. A PCR-based method (15) and the primers listed in Table
1 were used to introduce nucleotide
changes into the sequences of the following pit residues: V1091, P1153,
R1225, and P3179. Deep Vent polymerase (New England Biolabs) was used
in PCRs according to the manufacturer's instructions. The final PCR
products were separated by electrophoresis, gel purified, and cloned
into the SpeI-NdeI or
NdeI-AatII restriction endonuclease sites in
pGEM5zf(+). Dideoxynucleotide sequencing (Sequenase 2.0) confirmed the
presence of the expected mutations and excluded the introduction of
secondary mutations during PCR. After the nucleotide sequence was
confirmed, the 0.7-kb SpeI-NdeI or 0.3-kb
NdeI-AatII fragments replaced their parental
counterparts in the BeAn HindIII-KpnI
construct. Following restriction endonuclease digestion and gel
purification, the 1.6-kb AgeI-XhoI restriction fragment replaced that in parental BeAn in pGEM4. Plasmids were grown
in Escherichia coli DH5
cells.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic diagram of BeAn cDNA constructs used in
site-directed mutagenesis and assembly of infectious cDNA. Pit residues
are indicated by an *; L is the leader protein; P1, P2, and P3 are
the three coding parts of the genome.
|
|
In vitro transcription and transfection.
cDNA clones,
oriented with the 5' genomic end downstream of the T7 promoter, were
linearized at the XbaI site within the vector immediately
downstream of the virus poly(A) tail. Plus-strand RNA transcripts were
synthesized in reaction mixtures that contained 100 U of T7 RNA
polymerase and 1 µg of plasmid DNA as described previously
(5). Subconfluent BHK-21 cell monolayers in 60-mm dishes
were transfected with transcription reaction mixtures (5 µg of RNA)
with Lipofectin (Gibco-BRL) as specified by the supplier. To amplify
virus titers, progeny virus stocks were prepared after two additional
passages in BHK-21 cells. Both cells and supernatants were harvested
when there was >90% cytopathic effect and clarified supernatants were
obtained by sonication of the cells on ice (two 30-s bursts at a no. 2 setting of a Branson sonifier) followed by low-speed centrifugation.
Dideoxynucleotide sequencing.
Total RNA isolated from BHK-21
cells infected with mutant virus stocks with TriZol reagent (Gibco) was
reverse transcribed (1.2 µg of RNA in a 25-µl reaction mixture)
with Superscript II reverse transcriptase (Gibco) in the presence of
random primers (1.8 µM). Two microliters of each cDNA reaction was
PCR amplified in a 50-µl reaction mixture with negative-strand and
positive-strand primers equivalent to BeAn nucleotides 2753 to 3807. Gel-purified PCR products were sequenced using the ABI Prism 310 genetic analyzer (Perkin-Elmer Applied Biosystems).
Single- and multistep virus growth kinetics.
BHK-21 cell
monolayers were infected at a multiplicity of infection (MOI) of 10 in
96-well plates (single step) or of 0.2 in 24-well dishes (multistep).
Following adsorption for 45 min, monolayers were washed twice with
phosphate-buffered saline (PBS), pH 7.4, and incubated in DMEM medium
supplemented with 1% FBS. At each time point, triplicate or
quadruplicate wells were harvested and total virus yields were
determined from the virus in the supernatant and that released by the
freeze-thaw method. The growth kinetics for each virus was repeated at
least two times.
Virus RNA replication.
BHK-21 cell monolayers were infected
at an MOI of 10 in 96-well plates. Following virus adsorption for 45 min, monolayers were washed twice with PBS, and 100 µl of DMEM medium
per well, containing 10 µCi of [3H]uridine per ml and 5 µg of actinomycin D per ml, was added. At each time point,
quadruplicate wells were harvested with a PHD cell harvester (Cambridge
Technology, Inc., Watertown, Mass.) onto glass fiber filters.
Radioactivity was determined for the replicates with a Beckman LS5000TD
scintillation counter, and the mean and standard deviation were
calculated and graphed for each time point.
Thermal stability.
Virus samples containing 106
PFU/ml in 0.65-ml Eppendorf tubes were immersed in a 40°C water bath
for the indicated times, removed, and immediately plunged into liquid
nitrogen. Control samples (time zero) were transferred to liquid
nitrogen immediately following pipetting to triplicate tubes. The
amount of virus remaining at each time point was determined by plaque
assay. Thermostability represents the percent decline in virus titer
after heating at 40°C.
Virus purification.
Virus was purified as described
(30) with modifications (20). Specifically,
following virus adsorption, infected BHK-21 monolayers (in 100-mm
dishes) were incubated in maintenance medium for 5 h at 33°C,
washed twice with DMEM deficient in methionine and cysteine, and
incubated in this medium for 45 min at 33°C, and then deficient DMEM
medium containing 20 to 30 µCi of 35S-Trans label (ICN)
per ml was added. Infection was allowed to progress to complete the
cytopathic effect by 20 to 24 h postinfection. HEPES and
MgCl2 were added to the cells and supernatant to
concentrations of 25 mM and 20 mM, respectively, and bovine pancreatic
DNase I (Sigma Chemical) was added to a concentration of 10 µg/ml,
and the lysate was incubated for 30 min at 24°C. NaCl was added to 0.5 M and PEG-8000 to 10% (wt/vol) to the lysate, stirred for 1 h
at 24°C, and centrifuged in a Beckman HB-6 rotor at 10,000 × g for 30 min at 4°C. After resuspension of the pellet in
high-salt TNE buffer (20 mM Tris-HCl [pH 7.6], 0.5 M NaCl, 2 mM EDTA)
(hereafter designated hsTNE), sodium dodecyl sulfate (SDS) and PEG-8000
were added to 1 and 10% (wt/vol), respectively, stirred for 1 h
at 24°C, and centrifuged at 12,000 × g for 30 min at
15°C. The pellet, resuspended in hsTNE containing 1% bovine serum
albumin (BSA), 0.1% 2-mercaptoethanol (2ME), and 1% (wt/vol)
Sarkosyl, was layered over a 0.5-ml 30% sucrose cushion in hsTNE
containing 1% BSA and centrifuged in a Beckman SW 50.1 rotor at 45,000 rpm for 90 min at 10°C. The pellet, resuspended in 2 ml of hsTNE
containing 1% BSA, 0.1% 2ME, and 1% Sarkosyl, was layered on a 20 to
70% sucrose gradient in hsTNE and centrifuged in a SW41 rotor at
35,000 rpm for 3 h at 4°C. Gradients were fractionated from the
bottom into 0.5-ml aliquots, and radioactivity was measured in a
Beckman LS5000TD scintillation counter. The number of virus particles
was determined from the virus RNA content measured at an optical
density at 260 nm.
Estimation of physical particles.
To obtain an estimate of
the infectious particle-to-physical particle ratio for the different
viruses, we determined the TMEV RNA concentration of sucrose-gradient
purified viruses. The number of physical particles was calculated
assuming that 1 mg of picornavirus RNA is equivalent to 7.2 × 1013 virus genomes and to an equivalent number of virus
particles (28). The number of physical particles was then
related to the titer of the purified virus, as determined by a standard
plaque assay.
Binding assay and estimation of the attachment rate
constant.
BHK-21 cells were detached from monolayers with PBS
without calcium and magnesium, washed, resuspended to a concentration of 106 cells/ml in DMEM containing 20 mM HEPES and 1% BSA,
and incubated on ice for 1 h before the addition of
[35S]methionine-labeled virus (20,000 particles/cell). At
the indicated times, an aliquot of the virus-cell suspension was
removed and diluted in DMEM containing 20 mM HEPES before
centrifugation at 12,000 × g for 30 s. The
supernatant and cell-associated radioactivity were determined for
triplicate samples in a Beckman LS5000TD scintillation counter and
plotted as the percentage of cell-associated counts.
This interaction was considered as a first-order reaction; therefore,
the rate was measured from the initial slope of the
curve with the
equation
K = 2.3 log (
V0/
V)
Ct,
where
V0 is the
total amount of virus particles
added to 10
6 cells (
C), and
V is the
unattached virus in a period of time
(
t).
K
represents the attachment rate constant for the formation
of virus-cell
complexes (
11a,
28).
In vitro translation.
Translation reactions were carried out
at 30°C in rabbit reticulocyte lysates with a TNT Coupled
Transcription/Translation System (Promega) as specified by the
supplier. The translation reaction was terminated after 5 h by
transferring the sample tubes to
20°C or by the addition of Laemmli
sample buffer. Samples containing [35S]methionine-labeled
viral proteins were electrophoresed on 20% Ortec gels and exposed to
Kodak X-OMAT AR film. Protein synthesis was quantitated in triplicate
by trichloroacetic acid precipitation with precipitates collected on
glass fiber filters, and radioactivity was measured in a Beckman
LS5000TD scintillation counter.
 |
RESULTS |
Selection of pit residues for site-directed mutagenesis.
Pit
residues at the contact region of VP1 and VP3 are located 140 to 150 Å from the center of the virus particle; roadmaps of the BeAn pit
depicting the depression of the pit have been reported (32).
Residues V1091, P1153, A1225, and P3179 were chosen for site-directed
mutagenesis based on inspection of the atomic structures of BeAn, DA,
and GDVII viruses and on comparison of these structures with HRV-14
complexed with its receptor (26, 29). The first digit of the
residue identification signifies the viral protein, while the last
three digits give the amino acid sequence number within the protein.
The side chain of each selected residue, exposed within the pit,
projects into the solvent space (Fig. 2),
and the residues are located within a region homologous with the
intercellular adhesion molecule-1 (ICAM-1) footprint on the HRV-14
canyon (26). Interestingly, the BeAn virus atomic structure
was originally modeled on the mengovirus coordinates except for VP2
puff B, since the mengovirus VP2 puff B is truncated by 11 residues
compared to BeAn virus (27). However, we found that these
residues could be modeled within the HRV-14 VP2 puff B coordinates
(27). This indicates a similarity in structure in this
region (near the pit) and provides a rationale for using the ICAM-1
footprint on the HRV-14 canyon to select BeAn virus pit residues.

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 2.
Surface rendering with the program GRASP generated from
the atomic coordinates of BeAn, showing BeAn virion with one pentamer
in greater detail revealed at the top (A) and enlargement of the pit
showing the side chains of the mutated residues (highlighted in cyan)
projecting into the solvent space (B). R1225 and V1091 are slightly
recessed beneath the northwest rim of the pit; P1153 is partially
obscured in this view.
|
|
Stability and plaque morphology of the mutant viruses.
Each of
the pit residues was initially mutated to a small nonpolar amino acid,
alanine, except for residue 1091, which was mutated to an isoleucine.
Since each of the four mutant viruses was infectious, two additional
mutations were introduced into these sites. Thus, a total of 12 mutant
BeAn viruses were generated, but when reassembled into full-length
viral cDNA clones, only 8 of the mutant viruses yielded progeny virus
upon transfection of BHK-21 cells. The four nonviable mutant viruses
all represented more radical amino acid substitutions (Table
2). The sequence of the cDNAs prior to
transfection confirmed the presence of the mutation and demonstrated
the absence of mutations in the surrounding capsid sequences (see
Materials and Methods). To confirm that each pit mutation was stable
following transfection and two additional passages in BHK-21 cells,
total RNA was isolated from the infected cells, reverse transcribed,
and PCR amplified. The presence of the mutated residue was confirmed
for all of the viable mutant viruses except V1091G, which had reverted
to the parental codon. Compared to the BeAn parent, the seven viable
mutants showed differences in plaque size and/or particle-to-PFU ratio
(Table 2). Five of the seven mutants had a plaque morphology that
differed from the parent, although not all had a smaller plaque
phenotype (Fig. 3). P3179T and P3179D
formed plaques that were 40 and 60% larger, respectively, than those
of parental BeAn (Fig. 3).

View larger version (188K):
[in this window]
[in a new window]
|
FIG. 3.
Plaque phenotypes of parental BeAn and mutant viruses.
BHK-21 cell monolayers, infected with the viruses and overlaid with
1.6% Noble's agar in DMEM, were incubated at 33°C for 4 days and
stained with crystal violet. A, parental BeAn; B, V1091I; C, V1091G; D,
P1153A; E, R1225A; F, R1225S; G, P3179A; H, P3179T; I, P3179D. Mutants
V1091D, P1153T, P1153D, and R1225E were nonviable.
|
|
In vitro translation of viral RNAs.
Since the mutations were
introduced into the capsid protein VP1 or VP3, the function of the
nonstructural proteins, such as the viral polymerase (3D) and viral
protease (3C), should not be directly affected. To rule out the
possibility that the mutations might nevertheless induce a
conformational change in the P1 precursor protein that might impair
proteolytic processing by 3C, we tested the translational efficiency of
the polyprotein in in vitro translation assays of viral RNA in rabbit
reticulocyte lysates. Translation reactions were incubated for 5 h
at 30°C, and aliquots of each reaction were precipitated with
trichloroacetic acid to quantitate the level of total protein synthesis
and analyzed on a 20% Ortec gel. Both the total amount of viral
proteins synthesized (data not shown) and the pattern of processing of
the viral polyprotein into the final gene products were similar to that
of parental BeAn virus (Fig. 4). Thus,
the fact that four of the mutant viruses were nonviable does not rest
in a defect in polyprotein translation and proteolytic processing. Most
likely, these viruses had a lethal mutation affecting capsid assembly.

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 4.
In vitro translation of viral RNAs in rabbit
reticulocytes, demonstrating that the processing and migration of the
viral proteins of the mutant viruses, even the four that were
nonviable, were identical to that of the parental BeAn virus. Samples
were run on a 20% Ortec gel; the viral proteins are indicated.
|
|
Multistep growth kinetics of mutant viruses.
To analyze the
growth characteristics of the mutant viruses, BHK-21 monolayers were
infected at a low MOI (0.2), and virus yields were compared to that of
the BeAn parent. Mutants V1091I, P1153A, and R1225A, which formed
smaller plaques than BeAn, had reduced virus yields at 24 and 48 h, whereas mutants P3179T and P3179D, which formed slightly larger
plaques than the parental virus, had greater virus yields than BeAn
(Fig. 5). Mutant R1225S had a plaque size
similar to that of the parental virus, showed delayed growth at 24 h, but reached parental levels at 48 h. Thus, all of the amino
acid substitutions resulted in viruses with altered multistep growth
kinetics.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 5.
Multistep growth kinetics of BeAn and mutant viruses.
BHK-21 cell monolayers were infected with the indicated viruses at an
MOI of 0.2 PFU/cell. Following adsorption at 24°C, virus was removed
and the cells were washed and incubated in DMEM medium at 33°C. At 24 and 48 h, infected cells and supernatants were frozen and the
viral titers were determined by plaque assay. Each point represents the
mean and standard error of the mean (SEM) of triplicate samples. The
zero time point represents the titer of the input virus. PI,
postinfection.
|
|
Viral binding of mutant viruses to BHK-21 cells.
To compare
the cellular binding of mutant viruses to that of parental BeAn, the
kinetics of association of these 35S-labeled viruses to
BHK-21 cells in suspension was examined. Preliminary experiments
revealed saturable binding of [35S]methionine-labeled
BeAn virus to BHK-21 cells when increasing numbers of virions (Fig. 5)
or cells, i.e., receptors (Fig. 5), were added. The association
kinetics with subsaturating concentrations of virions was rapid, and
binding reached a maximum within 30 min (Fig. 5). The association
kinetics of the mutant viruses was determined using an equation of
linear regression in the early portion of the curve, where nonspecific
binding of the virus to a clonally derived BHK-21 receptor-negative
cell line was <10% (Fig. 5) (S. Hertzler and H. L. Lipton,
unpublished data). Comparison of the slopes of the linear regression
analysis revealed reduced binding in three of the mutant viruses
(V1091I, P1153A, and R1225A) (Fig. 5). Calculation of the attachment
rate constants showed a significant difference for only these
three mutant viruses (V1091I, P1153A, and R1225A) compared to BeAn
virus (Table 3). No significant difference in binding was observed for the three VP3 179 GH loop mutants, and R1225S showed no difference in its binding compared to
parental BeAn (Table 3).
Single-step growth kinetics of mutant viruses.
To assess
whether the amino acid substitutions affected viral processes distinct
from receptor attachment, BHK-21 cells were infected at a high MOI (5 to 10) to compensate for differences in mutant virus binding (Fig.
6) and the single-step growth kinetics of
the mutant viruses was compared to that of parental BeAn over 24 h. Due to the reduced titers for some of the mutant viruses (Table 2),
it was not feasible to further increase the MOI of the single-step
growth and RNA replication experiments. However, results from the RNA
replication (see below) indicate that an MOI of 5 to 10 overcomes
binding differences for V1091I, P1153A, and R1225A, as the kinetics and
levels of [3H]uridine incorporation resemble those
observed for parental BeAn. As shown in Fig.
7, all mutants were delayed in growth,
particularly between 6 and 12 h, except for V1091I in which the
kinetics of growth was faster in the early part of the curve (<6 h).
Final virus yields were similar to that of parental virus for all of the mutants except R1225A, which was reduced by 2 log10
units. The three 3179 mutants all showed a shallow eclipse phase
compared to the BeAn parent, suggestive of a defect in uncoating. These results suggest postattachment intracellular events were also affected
by the amino acid replacements in all of the mutant viruses.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 6.
(A and B) Saturation analysis of
[35S]methionine-labeled BeAn virus binding to BHK-21
cells. Increasing amounts of radiolabeled BeAn virus were incubated
with 106 BHK-21 cells/ml (A), and increasing numbers of
cells were incubated with a constant concentration of virus (2 × 104 particles/ml) (B). After 30 min at 4°C, the cell
suspension was diluted fivefold in DMEM and pelleted in a 1.5-ml
Eppendorf tube, and cell-associated radioactivity was determined.
Results are expressed as virus particles bound/cell (A) or percentage
of total radioactivity in the pellet fraction (B). Each point
represents the mean and standard deviation (SD) of triplicate samples.
(Error at most times was indiscernible.) (C) Association kinetics of
BeAn virus to BHK-21 or TMEV receptor-negative BHK-R26 cells in
suspension. [35S]methionine-labeled BeAn virus was
incubated with 106 cells/ml at a particle-to-cell ratio of
20,000:1 at 4°C. At the indicated times, cell-associated
radioactivity was determined. Results are expressed as the percentage
of total radioactivity in the cell pellet fraction; each point
represents the mean ± SEM of triplicate samples. , BHK-21 cell
binding; , R26 cell binding. (D) Binding kinetics over 12 min for
[35S]methionine-labeled BeAn ( ) and mutant viruses
( , V1091I; , P1153A; +, R1225A) assessed as
described for panel C.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 7.
Single-step growth kinetics of BeAn and the mutant
viruses. BHK-21 monolayers were incubated with virus (MOI, 5 to 10),
and after adsorption at 24°C, the cells were washed, overlaid with
DMEM maintenance medium, and incubated at 33°C. Cells and
supernatants were harvested at the indicated times and the virus titers
were determined by plaque assay. Zero time points represent the virus
titers immediately following the adsorption period. SD bars are shown
for BeAn and V1091I for triplicate independent growth curves. PI,
postinfection.
|
|
Viral RNA replication.
To determine whether the defects
unrelated to receptor binding affected viral replication, viral RNA
synthesis in BHK-21 cells infected at an MOI of 5 to 10 was measured
over 12 h as the cumulative incorporation of
[3H]uridine in the presence of actinomycin D. As shown in
Fig. 8, the kinetics of viral RNA synthesis in the mutants was
identical to that of BeAn and reached maximal levels by 12 h,
except for R1225S and P3179T. Replication of R1225S was delayed by
3 h throughout most of the time course yet reached parental levels
of isotope incorporation by 12 h. Both P3179T and P3179D were
apparently delayed initially but reached parental levels of
incorporation by 8 h. Since the three mutants did not differ from
parental BeAn in binding to BHK-21 cells, they may have a defect in a
step later than receptor attachment, such as in cell entry or uncoating.
Heat stability.
To assess the effect of the amino acid
replacements on capsid stability, the titer of the mutant viruses was
determined following heating to 40°C. Parental BeAn was quite
thermolabile, with a loss of >90% of the titer at 40°C by 10 min;
therefore, this temperature was used to determine the kinetics of
thermal inactivation of the mutant viruses (Fig.
9).
Substitutions at P3179 led to an increasingly more stable virion as the
replacement proceeded from conservative (P3179A) to more radical amino
acid (P3179D) replacements, with the phenotype of P3179T showing
intermediate values. Substitutions at R1225 also resulted in a more
heat-stable phenotype, most noticeably when the positively charged
arginine was replaced with the nonpolar alanine. Substitution with the
polar serine at this location resulted in a heat stability curve which
was less steep, i.e., more heat-stable, during the first half of the
time course, but then falling to the parental level of infectivity
during the latter half of the time course. Substitutions at V1091 and
P1153 had no effect on heat stability of these mutant viruses.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 8.
Viral RNA synthesis for BeAn and mutant viruses. BHK-21
cell monolayers were incubated with virus (MOI, 5 to 10) and after
adsorption at 24°C, cells were washed and incubated with DMEM
containing 5 µg of actinomycin D per ml and 10 µCi of
[3H]uridine per ml at 33°C. Cells were harvested at the
indicated times and the total incorporated radioactivity was determined
and expressed as counts per minute. Each point represents the mean ± SEM of quadruplicate samples; the error bars are not discernible
where the values are tightly clustered. PI, postinfection.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 9.
Stability of BeAn and mutant viruses to thermal
inactivation. Each virus was diluted to 106 PFU/ml in DMEM
and incubated at 40°C. At the indicated times, samples were removed
and the virus titer remaining was measured by plaque assay. Each point
represents the mean and SEM of triplicate samples; the error bars are
not discernible where the values are tightly clustered.
|
|
 |
DISCUSSION |
We have taken a direct approach to determine whether the
TMEV pit interacts with the host cellular receptor by evaluating the
effect of specific amino acid changes on binding as well as on the
subsequent steps in the life cycle of the mutant viruses. Based on
inspection of the crystallographic structures of three TMEV strains
solved to an atomic level (12, 21, 22) and a comparison with
HRV-14 complexed with its receptor, ICAM-1 (26, 29), we
introduced a series of single amino acid changes into a region within
and on the west wall of the pit that is likely to encompass the
receptor footprint. Previously, site-directed mutagenesis of HRV-14
indicated that substitution of four residues (1103, 1220, 1223 and
1273) in the floor of the canyon altered the binding affinity of HRV-14
to HeLa cell membranes (6). In addition, Harber et al.
(14) found that PV1 Mahoney viruses with mutation of canyon
residues 1089, 1166, and 1226 were greatly diminished in their ability
to bind to the wild-type human poliovirus receptor. Similar studies to
map the receptor binding sites on the surfaces of HRV-1A and
coxsackievirus 9A by site-directed mutagenesis have recently been
reported (A. Reischl and D. Blass, Abstr. 10th Meet. Eur. Study Group
on Mol. Biol. Picornaviruses, p82, 1998, and C. H. Williams,
P. J. Hughes, and G. Stanway, Abstr. 10th Meet. Eur. Study Group
on Mol. Biol. Picornaviruses, p107, 1999).
Mutation of three VP1 pit residues alters BeAn virus binding.
Our results suggest that the three VP1 amino acids which were mutated
(V1091, P1153, and A1225) are directly involved in BeAn virus binding
to the cellular receptor on BHK-21 cells. These mutations probably
alter the shape of the binding site and/or remove contact points for
the receptor residues.
Residue V1091.
The most conservative mutation, V1091I,
resulted in a mutant virus with decreased binding affinity for BHK-21
cells, while the other steps in the viral life cycle were not impaired.
The small plaque phenotype and reduced virus yields obtained in the multistep growth experiment likely reflect impaired receptor attachment of the mutant virus. When glycine was substituted at this site (V109G),
the mutant virus reverted to the parental sequence at this codon
(GUU
GGU), following transfection of BHK-21 cells on two
occasions. Substitution of the negatively charged aspartic acid
(V1091D) was lethal, further supporting the notion that residue 1091 is
critical in virus-receptor interaction. V1091 is located in the middle
of a hydrophobic pocket, with its side chain exposed at the virion
surface. While the V1091I mutation only modestly altered the
hydrophobic environment, substitution of the negatively charged residue
V1091D may have created new interactions with one of its nearest
neighbors, R1225, in turn inducing a lethal conformational change near
the boundary of VP1 and VP3, which are on neighboring protomers. V1091D
might also have severely disrupted the receptor interaction so that a
viable virus could not be recovered.
Residue P1153.
Residue P1153 was also sensitive to
substitutions, since replacing one nonpolar residue with another,
P1153A, produced a mutant with a drastically reduced binding affinity
to BHK-21 cells compared to the parent. While the single-step growth
kinetics was slightly delayed, viral RNA replication was normal,
localizing the nonattachment defect(s) for P1153A to a step after
binding but before RNA replication. We were unable to recover progeny
virus from the cDNAs with two other substitutions, P1153T and P1153D,
despite repeated transfection attempts. While P1153T and P1153D most
likely had such severely disrupted receptor interactions that viral
binding was completely abolished, a lethal effect on virion assembly
cannot be excluded.
Residue R1225.
Substitution of the positively charged R1225
with alanine gave rise to a virus with reduced binding and with
dramatically delayed single-step growth kinetics, indicating that
intracellular events were also affected. Viral RNA replication kinetics
indicated that most of the nonbinding phenotypic change resulting from
this replacement occurred at a step prior to RNA replication, probably at the level of cell entry and/or viral uncoating. R1225A showed increased thermal stability, raising the possibility that as the capsid
became more rigid and resistant to heat inactivation, the virus was
less able to undergo the structural transition required for uncoating.
In mutant R1225S, binding did not differ from that of the parent;
however, both single-step growth kinetics and RNA replication were
markedly delayed. Together, these data suggest that the mutation of
R1225A and R1225S altered the conformation of the pit and receptor
binding, as well as uncoating and assembly transitions.
Mutation of pit residue P3179 does not alter BeAn virus
binding.
Atomic resolution of the BeAn virus crystal structure
revealed close similarity to Mengovirus, another member of
the Cardiovirus genus (21). Conditions in
mengovirus crystals that order the GH loop in VP3 also correspond to
those that permit the virus to bind to and infect cells. These data
suggested a role for the pit in receptor binding for the cardioviruses,
and more specifically, localized a critical region of the pit to the
VP3 GH loop (17). Therefore, the role of the TMEV VP3 GH
loop in receptor binding was investigated by mutating residue P3179;
however, none of the replacements altered the binding phenotype of BeAn
virus. Although small differences were observed in the growth
characteristics of these viruses compared to parental BeAn, the most
dramatic change was an increase in thermal stability. Even the
conservative substitution of an alanine resulted in a stability
phenotype that was intermediate between those of parental BeAn and the
mutants with polar (P3179T) and charged polar (P3179D) substitutions at this site.
Temperature-sensitive (
ts) PV mutants have been described
(
11,
24). The majority of Sabin 3
ts suppressors
and all of
the soluble receptor-resistant mutants (
7) map to
the interface
between protomers. The stability of the protomer
interface is
believed to regulate structural transitions of the Sabin 3 strain
during assembly. One
ts suppressor and one soluble
receptor-resistant
mutant have the identical codon change at the same
position, Q3178L
(
7,
24), suggesting that capsid alterations
and receptor
binding have a common structural basis. When the antiviral
WIN
compounds bind in the hydrophobic pocket of HRV and prevent
uncoating,
several residues at the carboxyl end of VP1 are displaced
towards
the protomer interface (
3,
31). This creates more
extensive
interactions between the GH loops of VP1 and VP3, which act
to
stabilize the protomeric
interface.
In the present study, we found that mutation of a single residue in VP3
resulted in a virus with an increased plaque size
and a thermostable
phenotype. In the chimeras described by Adami
et al. (
2),
none exclusively replaced the BeAn VP3 with the
GDVII protein, although
one of the chimeras contained both GDVII
VP1 and VP3 in a BeAn
background; plaque sizes for this virus
were three to four times larger
and thermal stability was greater
than in the chimera in which only VP1
was replaced. However, this
chimera was much more compromised in its
single-step growth kinetics.
Similarly, P3179D, which produced large
plaques but was heat stable,
produced a larger yield of virus than
parental BeAn (Table
1).
By analogy with the rhinoviruses, mutations in
the BeAn VP3 GH
loop might lead to conformational changes that
stabilize the interaction
between the GH loop of VP1 and VP3 at the
protomer interface,
creating a capsid structure which uncoats less
efficiently. Together,
these data indicate that a balance exists
between structural stability
and the conformational flexibility needed
for uncoating and virion
assembly.
In summary, the altered binding phenotypes of the three VP1 pit mutant
viruses provide evidence that the pit is involved in
TMEV-receptor
interaction. Additional mutagenesis studies, and
most importantly,
identification of the cellular receptor for
TMEV followed by structural
analysis of the virus-receptor complex,
will be needed for a more
complete picture of TMEV-receptor
interactions.
 |
ACKNOWLEDGMENTS |
We thank Chris Pasko for technical assistance and Kathy Rundell
and Pat Spear for helpful discussions.
This work was supported by NIH grant NS23249 and The Leiper Trust.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Neurology, Evanston Hospital, 2650 Ridge Ave., Evanston, IL 60201-1782. Phone: (847) 570-2168. Fax: (847) 570-1568. E-mail:
hllipton{at}merle.acns.nwu.edu.
 |
REFERENCES |
| 1.
|
Acharya, R.,
E. Fry,
D. Stuart,
G. Fox,
D. Rowlands, and F. Brown.
1989.
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.
Nature
327:709-716.
|
| 2.
|
Adami, C.,
A. E. Pritchard,
T. Knauf,
M. Luo, and H. L. Lipton.
1997.
Mapping a determinant for central nervous system persistence in the capsid of Theiler's murine encephalomyelitis virus (TMEV) with recombinant viruses.
J. Virol.
71:1662-1665[Abstract].
|
| 3.
|
Badger, J.,
I. Minor,
M. J. Kremer,
T. J. Smith,
J. P. Griffith,
D. M. Guerin,
S. Krishnaswamy,
M. Luo, and M. G. Rossmann.
1988.
Structural analysis of a series of antiviral agents complexes with human rhinovirus 14.
Proc. Natl. Acad. Sci. USA
85:3308.
|
| 4.
|
Boege, U.,
D. Kobasa,
S. Onodera,
G. D. Parks,
A. C. Palmenberg, and D. G. Scraba.
1991.
Characterization of Mengo virus neutralization epitopes.
Virology
181:1-13[CrossRef][Medline].
|
| 5.
|
Calenoff, M. A.,
K. S. Faaberg, and H. L. Lipton.
1990.
Genomic regions of neurovirulence and attenuation in Theiler's murine encephalo-myelitis virus.
Proc. Natl. Acad. Sci. USA
87:978-982[Abstract/Free Full Text].
|
| 6.
|
Colonno, R. J.,
J. H. Condra,
S. Mizutani,
L. Pia,
M.-E. Davies, and M. A. Murcko.
1988.
Evidence for the direct involvement of the rhinovirus canyon in receptor binding.
Proc. Natl. Acad. Sci. USA
85:5449-5453[Abstract/Free Full Text].
|
| 7.
|
Colston, E., and V. R. Racaniello.
1994.
Soluble receptor-resistant polio-virus mutants identify surface and internal capsid residues that control interaction with the cell receptor.
EMBO J.
13:5855-5862[Medline].
|
| 8.
|
Colston, E. M., and V. R. Racaniello.
1995.
Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition.
J. Virol.
69:4823-4829[Abstract].
|
| 9.
|
Crane, M. A.,
C. Jue,
M. Mitchell,
H. Lipton, and B. S. Kim.
1990.
Detection of restricted predominant epitopes of Theiler's murine encephalomyelitis virus capsid proteins expressed in the lambda gt11 system: differential patterns of antibody reactivity among different mouse strains.
J. Neuroimmunol.
27:173-186[CrossRef][Medline].
|
| 10.
|
Duechler, M.,
S. Ketter,
T. Skern,
E. Kuechler, and D. Blaas.
1993.
Rhinoviral receptor discrimination: mutational changes in the canyon regions of human rhinovirus types 2 and 14 indicate a different site of interaction.
J. Gen. Virol.
74:2287-2291[Abstract/Free Full Text].
|
| 11.
|
Filman, D. J.,
R. Syed,
M. Chow,
A. J. Macadam,
P. D. Minor, and J. M. Hogle.
1989.
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus.
EMBO J.
8:1567-1579[Medline].
|
| 11a.
|
Fotiatdis, C.,
D. R. Kilpatrick, and H. L. Lipton.
1991.
Comparison of binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups.
Virology
182:365-370[CrossRef][Medline].
|
| 12.
|
Grant, R. A.,
D. J. Filman,
R. S. Fujinami,
J. P. Icenogle, and J. M. Hogle.
1992.
Three-dimensional structure of Theiler's virus.
Proc. Natl. Acad. Sci. USA
89:2061-2065[Abstract/Free Full Text].
|
| 13.
|
Hadfield, A. T.,
W.-M. Lee,
R. Zhao,
M. A. Oliveira,
I. Minor,
R. R. Rueckert, and M. G. Rossmann.
1997.
The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Structure
5:427-441[Medline].
|
| 14.
|
Harber, J.,
G. Bernhardt,
H. H. Lu,
J.-Y. Sgro, and E. Wimmer.
1995.
Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
Virology
214:559-570[CrossRef][Medline].
|
| 15.
|
Higuchi, R.,
B. Krummel, and R. K. Saiki.
1988.
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.
Nucleic Acids Res.
16:7351-7367[Abstract/Free Full Text].
|
| 16.
|
Hogle, J. M.,
M. Chow, and D. J. Filman.
1985.
Three-dimensional structure of poliovirus at 2.9 A resolution.
Science
229:1358-1365[Abstract/Free Full Text].
|
| 17.
|
Kim, S.,
U. Boege,
S. Krishnaswamy,
I. Minor,
T. J. Smith,
M. Luo,
D. G. Scraba, and M. G. Rossmann.
1990.
Conformational variability of a picornavirus capsid: pH-dependent structural changes of Mengo virus related to its host receptor attachment site and disassembly.
Virology
175:176-190[CrossRef][Medline].
|
| 18.
|
Kim, S.,
T. J. Smith,
M. S. Chapman,
M. G. Rossmann,
D. C. Pevear,
F. J. Dutko,
P. J. Felock,
G. D. Diana, and M. A. McKinlay.
1989.
Crystal structure of human rhinovirus serotype 1A (HRV1A).
J. Mol. Biol.
210:91-111[CrossRef][Medline].
|
| 19.
|
Kobasa, D.,
M. Mulvey,
J. S. Lee, and D. G. Scraba.
1995.
Characterization of Mengo virus neutralization epitopes. II. Infection of mice with an attenuated virus.
Virology
214:118-127[CrossRef][Medline].
|
| 20.
|
Lipton, H. L., and A. Friedmann.
1980.
Purification of Theiler's murine encephalomyelitis virus and analysis of structural virion polypeptides. Correlation of structural polypeptide composition with virulence.
J. Virol.
33:1165-1172[Abstract/Free Full Text].
|
| 21.
|
Luo, M.,
C. He,
K. S. Toth,
C. X. Zhang, and H. L. Lipton.
1992.
Three-dimensional structure of Theiler's murine encephalomyelitis virus (BeAn strain).
Proc. Natl. Acad. Sci. USA
89:2409-2413[Abstract/Free Full Text].
|
| 22.
|
Luo, M.,
K. S. Toth,
L. Zhou,
A. Pritchard, and H. L. Lipton.
1995.
The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence.
Virology
220:246-250.
|
| 23.
|
Luo, M.,
G. Vriend,
G. Kamer,
I. Minor,
E. Arnold,
M. G. Rossmann,
U. Boege,
D. G. Scraba,
G. M. Duke, and A. C. Palmenberg.
1987.
The atomic structure of Mengo virus at 3.0 A resolution.
Science
235:182-191[Abstract/Free Full Text].
|
| 24.
|
Minor, P. D.,
G. Dunn,
D. Evans,
D. I. Magrath,
A. John,
J. Howlett,
A. Phillips,
G. Westrop,
K. Wareham,
J. W. Almond, and J. M. Hogle.
1989.
The temperature sensitivity of the Sabin type 3 strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3.
J. Gen. Virol.
70:1117-1123[Abstract/Free Full Text].
|
| 25.
|
Muckelbauer, J. K.,
M. Kremer,
I. Minor,
G. Diana,
F. J. Dutko,
J. Groarke,
D. C. Pevear, and M. G. Rossmann.
1999.
The structure of coxsackievirus B3 at 3.5 A resolution.
Structure
3:653-667[CrossRef].
|
| 26.
|
Olson, N. H.,
P. R. Kolatkar,
M. S. Oliveira,
R. H. Cheng,
J. M. Greve,
A. McClelland,
T. S. Baker, and M. G. Rossmann.
1993.
Structure of a human rhinovirus complexed with its receptor molecule.
Proc. Natl. Acad. Sci. USA
90:507-511[Abstract/Free Full Text].
|
| 27.
|
Pevear, D. C.,
M. Luo, and H. L. Lipton.
1988.
Three-dimensional model of the capsid proteins of two biologically different Theiler's virus strains: clustering of amino acid differences identifies possible locations of immunogenic sites of the virion.
Proc. Natl. Acad. Sci. USA
85:4496-4500[Abstract/Free Full Text].
|
| 28.
|
Rueckert, R. R.
1996.
Picornaviridae: the viruses and their replication, p. 609-654.
In
B. N. Fields, D. N. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven Press, New York, N.Y.
|
| 29.
|
Rossmann, M. G.,
E. Arnold,
J. W. Erickson,
E. A. Frankenberger,
J. P. Griffith,
H.-J. Hecht,
J. E. Johnson,
G. Kamer,
M. Luo,
A. G. Mosser,
R. R. Rueckert,
B. Sherry, and G. Vriend.
1985.
Structure of a human common cold virus and functional relationship to other picornaviruses.
Nature
317:145-153[CrossRef][Medline].
|
| 30.
|
Rozhon, E. J.,
J. D. Kratochvil, and H. L. Lipton.
1983.
Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system.
Virology
128:16-32[CrossRef][Medline].
|
| 31.
|
Smith, T. J.,
M. Kremer,
M. Luo,
G. Vriend,
E. Arnold,
G. Kamer,
M. G. Rossmann,
M. A. McKinlay,
G. Diana, and M. J. Otto.
1986.
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
Science
233:1286-1293[Abstract/Free Full Text].
|
| 32.
|
Zhou, L.,
X. Lin,
T. J. Green,
H. L. Lipton, and M. Luo.
1997.
Role of sialyloligosaccharide binding in Theiler's virus persistence.
J. Virol.
71:9701-9712[Abstract].
|
Journal of Virology, February 2000, p. 1994-2004, Vol. 74, No. 4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Reddi, H. V., Kallio, P., Lipton, H. L.
(2003). Galactose is needed only for expression of co-receptors used by Theiler's murine encephalomyelitis virus as the virus does not directly bind galactose or use the UDP-galactose transporter as a receptor. J. Gen. Virol.
84: 845-849
[Abstract]
[Full Text]
-
Kumar, A. S. M., Kallio, P., Luo, M., Lipton, H. L.
(2003). Amino Acid Substitutions in VP2 Residues Contacting Sialic Acid in Low-Neurovirulence BeAn Virus Dramatically Reduce Viral Binding and Spread of Infection. J. Virol.
77: 2709-2716
[Abstract]
[Full Text]
-
Jnaoui, K., Minet, M., Michiels, T.
(2002). Mutations That Affect the Tropism of DA and GDVII Strains of Theiler's Virus In Vitro Influence Sialic Acid Binding and Pathogenicity. J. Virol.
76: 8138-8147
[Abstract]
[Full Text]
-
Trottier, M., Kallio, P., Wang, W., Lipton, H. L.
(2001). High Numbers of Viral RNA Copies in the Central Nervous System of Mice during Persistent Infection with Theiler's Virus. J. Virol.
75: 7420-7428
[Abstract]
[Full Text]
-
Hertzler, S., Trottier, M., Lipton, H. L.
(2000). Selection and characterization of a BHK-21 cell line resistant to infection by Theiler's murine encephalomyelitis virus due to a block in virus attachment and entry. J. Gen. Virol.
81: 2485-2490
[Abstract]
[Full Text]